|August 15, 2017
Join a conversation with US government research leadership about the future of investments in the US National Institutes of Health’s (NIH) HIV clinical trial research networks in the US and internationally. Mark your calendar for Tuesday, September 5 at 2pm ET for a conversation with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases. (Check other time zones here.)
Every seven years, the NIH reviews the structure and funding of its HIV clinical research networks. This “network recompetition” process involves decisions that will help determine the focus and priorities of its HIV clinical trial networks through 2027, as well as the number and structures of the various networks that undertake this research. These are critical questions for advocates to weigh in on—whether you are in the US or not.
The webinar will include a brief introductory presentation from Dr. Dieffenbach followed by a Q&A session. NIAID is also currently accepting public comments and questions online, so now is your chance!
Can’t make the webinar but have a question? Please send it on! We will also be scheduling a second webinar at a time more convenient time for advocates outside of the US. And, as always, slides and a recording will be posted shortly after the conclusion of the webinar.